{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:30:24Z","timestamp":1771327824691,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijid.2024.107047","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:09:07Z","timestamp":1712797747000},"page":"107047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-7436","authenticated-orcid":false,"given":"Surasith","family":"Chaithongwongwatthana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassana","family":"Wijagkanalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-275X","authenticated-orcid":false,"given":"Nasamon","family":"Wanlapakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Librada","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilasinee","family":"Yuwaree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawanee","family":"Kerdsomboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrajeet Kumar","family":"Poredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souad","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Thai","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107047_bib0001","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2015.10.136","article-title":"Pertussis vaccines: WHO position paper, August 2015\u2014recommendations","volume":"34","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0002","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mSphere.00221-18","article-title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): toward integrating maternal and infant immunization programs","volume":"3","author":"Munoz","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.ijid.2024.107047_bib0003","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2015.07.085","article-title":"Maternal antibodies and infant immune responses to vaccines","volume":"33","author":"Edwards","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0004","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fmicb.2020.01499","article-title":"Maternal immunization: nature meets nurture","volume":"11","author":"Saso","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2024.107047_bib0005","unstructured":"US Centers for Disease Control and Prevention. Pertussis: summary of vaccine recommendations, https:\/\/www.cdc.gov\/vaccines\/vpd\/pertussis\/recs-summary.html; 2020 [accessed 10 January 2024]."},{"key":"10.1016\/j.ijid.2024.107047_bib0006","unstructured":"NHS. NHS vaccinations and when to have them, https:\/\/www.nhs.uk\/conditions\/vaccinations\/nhs-vaccinations-and-when-to-have-them\/; 2023 [accessed 10 January 2024]."},{"key":"10.1016\/j.ijid.2024.107047_bib0007","unstructured":"ECDC. Pertussis: recommended vaccinations, https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=3&SelectedCountryIdByDisease=-1; 2022 [accessed 10 January 2024]."},{"key":"10.1016\/j.ijid.2024.107047_bib0008","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12884-017-1559-2","article-title":"Efficacy and safety of pertussis vaccination for pregnant women\u2014a systematic review of randomised controlled trials and observational studies","volume":"17","author":"Furuta","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ijid.2024.107047_bib0009","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2024.107047_bib0011","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0264-410X(95)00230-X","article-title":"The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies","volume":"14","author":"Ibsen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0012","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1542\/peds.2014-3358","article-title":"Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic","volume":"135","author":"Acosta","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2024.107047_bib0013","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2024.107047_bib0014","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.vaccine.2006.12.013","article-title":"The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP","volume":"25","author":"Robbins","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2180-12-61","article-title":"Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated pertussis toxin and pertactin by unmarked allelic exchange","volume":"12","author":"Buasri","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijid.2024.107047_bib0016","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1473-3099(17)30612-6","article-title":"A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2\/3, randomised controlled non-inferiority trial","volume":"18","author":"Sricharoenchai","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2024.107047_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100976","article-title":"Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines","volume":"37","author":"Pitisuttithum","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2024.107047_bib0018","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.vaccine.2021.10.076","article-title":"A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age","volume":"40","author":"Chokephaibulkit","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0019","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2023.06.001","article-title":"A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women","volume":"31","author":"Puthanakit","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.vaccine.2023.11.042","article-title":"Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines","volume":"42","author":"Chokephaibulkit","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0021","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1016\/j.vaccine.2020.10.070","volume":"38","author":"Fortuna","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0022","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw027","article-title":"Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis","volume":"62","author":"Eberhardt","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107047_bib0023","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.vaccine.2018.01.059","article-title":"Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women","volume":"36","author":"Wanlapakorn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0024","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1016\/j.vaccine.2020.06.050","article-title":"Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy","volume":"38","author":"Healy","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2024.107047_bib0025","doi-asserted-by":"crossref","first-page":"e1087","DOI":"10.1093\/cid\/ciac432","article-title":"Maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during pregnancy: impact on infant anti-pertussis antibody concentrations by maternal pertussis priming series","volume":"76","author":"Havers","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2024.107047_bib0026","first-page":"100","article-title":"The incidence and risk factors for preterm delivery in Northeast Thailand","volume":"29","author":"Kinpoon","year":"2021","journal-title":"Thai J Obstet Gynaecol"},{"key":"10.1016\/j.ijid.2024.107047_bib0027","unstructured":"World Health Organization. Preterm birth, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth#:~:text=Preterm%20is%20defined%20as%20babies,preterm%20(28%20to%2032%20weeks; 2023 [accessed 10 January 2024]."},{"key":"10.1016\/j.ijid.2024.107047_bib0028","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2024.107047_bib0029","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14760584.2020.1791092","article-title":"A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis","volume":"19","author":"Kandeil","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2024.107047_bib0030","unstructured":"National Health Security Office (NHSO) Thailand. Acellular pertussis vaccines offered to pregnant women. Thailand, https:\/\/eng.nhso.go.th\/view\/1\/home\/News\/536\/EN-US; 2023 [accessed 10 January 2024]."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:00:20Z","timestamp":1716951620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S1201971224001152"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107047","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107047"}}